These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7923049)

  • 1. Molecular adjuvants and immunomodulators: new approaches to immunization.
    Johnson AG
    Clin Microbiol Rev; 1994 Jul; 7(3):277-89. PubMed ID: 7923049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic immunomodulators and synthetic vaccines.
    Leclerc C; Vogel FR
    Crit Rev Ther Drug Carrier Syst; 1986; 2(4):353-406. PubMed ID: 3103928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological adjuvants and their modes of action.
    Allison AC
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):141-7. PubMed ID: 9597079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adjuvant systems.
    McCluskie MJ; Weeratna RD
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):263-71. PubMed ID: 12455400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant activities of synthetic lipid A subunit analogues and its conjugates with muramyl dipeptide derivatives.
    Maeda H; Saiki I; Ishida H; Kiso M; Hasegawa A; Azuma I
    Vaccine; 1989 Jun; 7(3):275-81. PubMed ID: 2675486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of gamma interferon in antibody enhancement by adjuvants.
    Odean MJ; Frane CM; Van derVieren M; Tomai MA; Johnson AG
    Infect Immun; 1990 Feb; 58(2):427-32. PubMed ID: 2105274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
    Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal preparations of muramyl glycopeptides as immunomodulators and adjuvants.
    Turánek J; Ledvina M; Kasná A; Vacek A; Hríbalova V; Krejcí J; Miller AD
    Vaccine; 2006 Apr; 24 Suppl 2():S2-90-1. PubMed ID: 16823942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes, muramyl dipeptide derivatives, and nontoxic lipid A derivatives as adjuvants for human malaria vaccines.
    Hui GS
    Am J Trop Med Hyg; 1994; 50(4 Suppl):41-51. PubMed ID: 8172331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
    Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
    Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
    Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological adjuvants and their mode of action.
    Allison AC; Byars NE
    Biotechnology; 1992; 20():431-49. PubMed ID: 1600387
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of muramyl dipeptides in models of synthetic vaccines].
    Audibert F
    Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.
    Ott G; Barchfeld GL; Van Nest G
    Vaccine; 1995 Nov; 13(16):1557-62. PubMed ID: 8578842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
    Osada Y; Mitsuyama M; Matsumoto K; Une T; Otani T; Ogawa H; Nomoto K
    Infect Immun; 1982 Sep; 37(3):1285-8. PubMed ID: 6752024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodifiers of bacterial origin.
    Le Garrec Y
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):137-41. PubMed ID: 3791953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muramyl peptides: immunomodulators, sleep factors, and vitamins.
    Adam A; Lederer E
    Med Res Rev; 1984; 4(2):111-52. PubMed ID: 6374337
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.